Historic Santa Claus Campground has received an $861,224 grant from Lilly Endowment Inc. through its Capital Project ...

GERBER MULTITOOLS LINKSBladehq** <a href=" <a href=" <a href=" Mountain Knife Works** <a href=" Gear Link Hub: <a href=" ...

How Did He Build This Underground Mansion By Hand? Top Four videos Thank you very much for your valuable time to Watch, Like, ...

Eli Lilly stock has soared in the triple digits over three years. Investors are excited about the company’s portfolio of weight loss drugs, which has generated blockbuster revenue. The stock recently ...

A fresh call from Bernstein has Wall Street doing a double-take. Bernstein just reset Eli Lilly’s price target. Analyst Breen cites talks about GLP-1 catalysts, robust U.S. policy, and promising ...

Philadelphia is about to become the host of the fifth Lilly Gateway Labs, a biotech incubator for early-stage companies backed by Eli Lilly & Co., writes Harold Brubaker for The Philadelphia Inquirer.

LillyDirect is a legitimate, direct-to-consumer platform that offers authentic Eli Lilly medication. This platform accepts insurance and offers self-pay options. LillyDirect is partnered with licensed ...

Eli Lilly’s stock (NYSE: LLY) soared nearly 50%, in the past six months, driven not only by outstanding earnings and a notable margin increase, but also by reaching a $1T market cap and excitement ...

Whether repurposing a song by The Beatles or leveraging the starpower of Academy Award-winner Julianne Moore, Eli Lilly has amplified several ad campaigns focused on Alzheimer’s disease and brain ...

Eli Lilly is continuing its recent pattern of tying disease awareness-raising efforts to major pop cultural moments. The latest high-profile crossovers—which include a starry TV partnership and the ...

Pharmaceutical company Eli Lilly is looking to roll out a daily weight loss pill for patients with obesity and type 2 diabetes. A recent trial showed the drug enabled people with both conditions to ...

Eli Lilly delivered 54% revenue growth in Q3 2025, raised full-year guidance, and remains a defensive haven amid market volatility. LLY's obesity and diabetes franchise, led by Zepbound, Mounjaro, and ...